Don't Jump to Newer Diabetes Meds for Renal Protection Yet
You may hear about using SGLT2 inhibitors (empagliflozin, etc) or GLP-1 agonists (liraglutide, etc) for renal protection in type 2 diabetes.
We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.
Now growing data suggest certain SGLT2 inhibitors or GLP-1 agonists may also offer renal protection...independent of blood glucose lowering.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals